NCT04330781CompletedPhase 2
Radiotherapy of Head and Neck Cancer Using an Intraoral Stent
Patient-reported Outcome After Radiotherapy of Oral Cavity and Sinonasal Cancer Using an Intraoral Stent
Source: ClinicalTrials.gov · Last updated 9 Jul 2025
Brief summary (registry, in English)
Radiotherapy of oral cavity cancer and sinonasal cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The aim of the present study is to confirm that an intraoral stent is not a significant bother to the patients.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (actual)
- First submitted
- 31 Mar 2020
- Start date
- 1 Jan 2020
- Primary completion date
- 3 Jul 2025
- Lead sponsor
- Oslo University Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT04330781
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 220
- From 1 Jan 2020 to the primary completion date, 3 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Radiation dose 30 Gy or higher
- Cancer in the inferior part of the oral cavity (e.g. tongue or floor of mouth cancer) or superior part of the oral cavity (e.g. hard palate) or sinonasal cancer
- Eastern Cooperative Oncology Group (ECOG) performance status 0-3
- Ability to understand and answer questionnaire
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.